Gilead Sciences
GILD
#131
Rank
โ‚น13.308 T
Marketcap
โ‚น10,726
Share price
-1.51%
Change (1 day)
42.71%
Change (1 year)

Revenue for Gilead Sciences (GILD)

Revenue in 2025 (TTM): โ‚น2.516 Trillion

According to Gilead Sciences's latest financial reports the company's current revenue (TTM ) is โ‚น2.613 Trillion. In 2024 the company made a revenue of โ‚น2.466 Trillion an increase over the revenue in the year 2023 that were of โ‚น2.257 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Gilead Sciences from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น2.516 T2.01%
2024 โ‚น2.466 T9.27%
2023 โ‚น2.257 T-0.01%
2022 โ‚น2.257 T11.08%
2021 โ‚น2.032 T12.56%
2020 โ‚น1.805 T12.79%
2019 โ‚น1.600 T3.47%
2018 โ‚น1.547 T-7.19%
2017 โ‚น1.666 T-19.28%
2016 โ‚น2.065 T-4.79%
2015 โ‚น2.169 T37.5%
2014 โ‚น1.577 T127.95%
2013 โ‚น692.04 B30.27%
2012 โ‚น531.24 B19.76%
2011 โ‚น443.58 B24.53%
2010 โ‚น356.21 B9.49%
2009 โ‚น325.32 B26.85%
2008 โ‚น256.46 B54.49%
2007 โ‚น166.00 B23.86%
2006 โ‚น134.02 B46.83%
2005 โ‚น91.27 B59.11%
2004 โ‚น57.36 B45.18%
2003 โ‚น39.51 B76.52%
2002 โ‚น22.38 B98.45%
2001 โ‚น11.27 B21.94%
2000 โ‚น9.25 B25.9%
1999 โ‚น7.34 B180.98%
1998 โ‚น2.61 B66.35%
1997 โ‚น1.57 B30.53%
1996 โ‚น1.20 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
โ‚น3.232 T 23.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น1.053 T-59.69%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น5.359 T 105.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น385.31 B-85.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น904.51 B-65.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.641 T 115.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.280 T 216.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น5.339 T 104.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น5.772 T 120.85%๐Ÿ‡บ๐Ÿ‡ธ USA